24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
ScaleUp House
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
Corporate
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Nasdaq
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
ScaleUp House
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
Corporate
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
19:02
With 99% counted, Israel’s election leaves parliament deadlocked
16:23
"AI stands on infrastructure of power and land"
16:22
"Don't chase the new trend. The trend is not your friend"
16:22
"The innovation and the DNA are still here"
More stories
Buzz
Most popular
Daily
Weekly
1
Intel’s $2.3 billion Classiq deal follows years of personal investment by Lip-Bu Tan
2
Nikesh Arora's pay falls 19.5% to $80 million as Palo Alto Networks board lowers cap on stock awards
3
Stealth Israeli cyber startup valued at over $1.5 billion recruits former 8200 chief
4
Intel to acquire Israeli quantum startup Classiq for $2.3 billion
5
Microsoft offers buyouts to 60,000 workers but says layoffs remain an option
More news
Nasdaq
2 stories about Nasdaq
Acne Cream Developer Sol-Gel files for $86 Million Nasdaq IPO
31.08.17
|
Dror Reich
The clinical-stage drug developer will remain a "controlled company" under current shareholder Arkin Dermatology
Anti-Acne Drug Developer Plans Nasdaq IPO
15.08.17
|
Golan Hazani
Sol-Gel approached potential underwriters. It aims to go public before the end of the year
Previous Articles
